j.habermann
TL3 Regular · Ljubljana, SI
Journal club attendee. Interested in trial design more than in trial conclusions.
Joined 2 September 2024 · last posted 2d · groups: journal-club
141 posts, newest first. Showing up to 150.
-
Priming a pen and whether the primed volume is wasted Replied, post #24 · Devices › Pens & autoinjectors · 26 Jul 2026 · 23 likes Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty. Confirm which type you have. Reusing a single-use pen is…
-
A revision dispute resolved on the topic rather than in the history Replied, post #15 · Meta › Wiki maintenance · 22 Jul 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Which categories are strict and which are relaxed, honestly Replied, post #39 · Start Here › Welcome · 22 Jul 2026 · 29 likes Picking up post #36: that is the part I would want checked first. Marked solutions are the site's way of saying that someone asked a good question and someone else gave…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #87 · Practice › Dosing & titration · 22 Jul 2026 · 2 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #21 · Clinical › Bloodwork · 21 Jul 2026 · 2 likes This follows post #18 rather than contradicting it. HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment.…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #113 · Devices › Syringes & needles · 20 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
How shortages have affected compounding permissions Replied, post #48 · Access › Shortages · 18 Jul 2026 · 21 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
-
Journal club: what we got wrong in an earlier session Replied, post #91 · Evidence › Journal club · 17 Jul 2026 · 13 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #92 · Analytics › Home & field testing · 16 Jul 2026 · 15 likes On post #88 — agreed on the reasoning, with one qualification. What you can use home tests for: confirmation that a solution contains peptide (as opposed to being…
-
Tracking a shortage from primary sources rather than rumour Replied, post #98 · Access › Shortages · 12 Jul 2026 · 0 likes On post #94 — agreed on the reasoning, with one qualification. Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #77 · Analytics › Home & field testing · 12 Jul 2026 · 12 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #19 · Practice › Interactions · 7 Jul 2026 · 2 likes On post #15 — agreed on the reasoning, with one qualification. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #24 · Evidence › Journal club · 5 Jul 2026 · 0 likes Coming back to post #22, because the follow-up matters more than the original answer. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes.…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #52 · Compounds › Repair & healing peptides · 2 Jul 2026 · 18 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #90 · Analytics › HPLC & UHPLC · 30 Jun 2026 · 23 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
I have no scientific background — can I still follow the analytics categories? Replied, post #24 · Start Here › Welcome · 21 Jun 2026 · 12 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #64 · Meta › Announcements · 14 Jun 2026 · 0 likes RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for this subcategory.
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #34 · Compounds › Secretagogues & GH axis · 13 Jun 2026 · 7 likes post #33 answers the question as asked. The question underneath it is different. Secretagogues and glucose tolerance: there is a mechanistic concern that sustained…
-
Packaging that arrived damaged: documenting it properly Replied, post #23 · Sourcing › Logistics · 11 Jun 2026 · 14 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…
-
Reading a trial's population section before its results Replied, post #97 · Evidence › Trials · 7 Jun 2026 · 0 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
-
Packaging that arrived damaged: documenting it properly Replied, post #16 · Sourcing › Logistics · 28 May 2026 · 2 likes Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier choice and should be understood before ordering in a…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #36 · Start Here › Welcome · 21 May 2026 · 6 likes post #35 is right about the mechanism and I think understates the practical bit. Introducing yourself is fine and requires no question. Post in this subcategory,…
-
The arithmetic of an intermediate dose between two label steps Replied, post #2 · Practice › Dosing & titration · 21 May 2026 · 21 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
The anatomy of a question that gets answered within an hour Replied, post #49 · Start Here › How to Ask · 18 May 2026 · 0 likes Worth separating two things that post #45 runs together. Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #31 · Clinical › Bloodwork · 11 May 2026 · 22 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Why the timeline is on the right and not the left — what changed since Replied, post #33 · Meta › Site feedback · 9 May 2026 · 16 likes Navigation problems: if you cannot find something you expected to exist, or the path to it is unclear, report it. Site architecture affects usability.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #38 · Practice › Reconstitution · 7 May 2026 · 0 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Request: show the solution author in the topic list — what changed since Replied, post #3 · Meta › Feature requests · 29 Apr 2026 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #110 · Practice › Reconstitution · 25 Apr 2026 · 15 likes Worth separating two things that post #106 runs together. How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #16 · Compounds › Repair & healing peptides · 25 Apr 2026 · 23 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #28 · Practice › Interactions · 18 Apr 2026 · 9 likes This follows post #25 rather than contradicting it. Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking…
-
Follow-up: Lyophilisation and why the cake looks the way it does Replied, post #14 · Pharmacology › Formulation chemistry · 16 Apr 2026 · 15 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Subgroup analyses: pre-specified versus discovered Started this topic · Evidence › Trials · 16 Apr 2026 · 0 likes Subgroup analyses: pre-specified versus discovered — setting out what I have, and where I think it stops being reliable. Comparing SURMOUNT-2 ( Lancet , 2023) with…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #19 · Practice › Administration · 25 Mar 2026 · 31 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Research-use-only status: what it means legally and practically Replied, post #17 · Compounds › Other compounds · 21 Mar 2026 · 25 likes This follows post #14 rather than contradicting it. When "no data" is the complete and final answer: if there is no published human data on a compound, that is the…
-
Grapefruit: why this class is not the class that cares Replied, post #54 · Practice › Interactions · 18 Mar 2026 · 6 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #12 · Lounge › Introductions · 8 Mar 2026 · 3 likes This follows post #9 rather than contradicting it. Welcome: the response to introductions is usually welcome. People will reply to introduce themselves back or to let…
-
Adolescents: a distinct evidence base — one year on Replied, post #70 · Clinical › Special populations · 2 Mar 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Dead volume across syringe and needle combinations Replied, post #79 · Devices › Syringes & needles · 27 Feb 2026 · 4 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
MHRA statements, read directly Replied, post #94 · Regional › UK & Ireland · 22 Feb 2026 · 14 likes Coming back to post #92, because the follow-up matters more than the original answer. Supply and shortage resilience: both UK and Ireland sourced primarily from…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #49 · Data & Tools › Calculators · 16 Feb 2026 · 18 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #23 · Practice › Interactions · 15 Feb 2026 · 14 likes post #22 answers the question as asked. The question underneath it is different. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin…
-
Waist circumference technique and its repeatability Replied, post #51 · Outcomes › Progress reports · 14 Feb 2026 · 1 like Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the scale. Noting exercise changes when reporting weight helps…
-
Trifluoroacetate content and its consequences Replied, post #95 · Analytics › Impurities & related substances · 6 Feb 2026 · 14 likes This follows post #92 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #57 · Compounds › Semaglutide · 18 Jan 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #12 · Practice › Side effects · 13 Jan 2026 · 8 likes Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
Amylin receptor signalling and satiety — what changed since Replied, post #14 · Pharmacology › Receptor biology · 9 Jan 2026 · 13 likes Picking up post #11: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #8 · Evidence › Journal club · 9 Jan 2026 · 1 like On post #4 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #3 · Practice › Side effects · 30 Dec 2025 · 4 likes Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
Heterogeneity as information rather than as a nuisance Replied, post #40 · Evidence › Meta-analyses · 27 Dec 2025 · 24 likes When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
-
Preprint servers and what screening they do Replied, post #9 · Evidence › Preprints · 27 Dec 2025 · 24 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #15 · Compounds › Cagrilintide & amylin analogues · 24 Dec 2025 · 9 likes Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic or additive. Synergy is a mechanistic claim that…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #74 · Compounds › Semaglutide · 21 Dec 2025 · 0 likes Coming back to post #72, because the follow-up matters more than the original answer. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #6 · Practice › Administration · 17 Dec 2025 · 6 likes Picking up post #3: that is the part I would want checked first. Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #10 · Sourcing › Red flags · 9 Dec 2025 · 30 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #64 · Practice › Interactions · 7 Dec 2025 · 26 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Tracking a preprint to publication: a worked example Replied, post #60 · Evidence › Preprints · 6 Dec 2025 · 7 likes Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
-
Prescription requirements and telehealth models Replied, post #49 · Sourcing › Regulatory · 5 Dec 2025 · 18 likes I read post #47 twice before replying, because I had assumed the opposite. Import restrictions vary by compound and by jurisdiction: what is a controlled substance in…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #18 · Compounds › Tirzepatide · 2 Dec 2025 · 3 likes Picking up post #15: that is the part I would want checked first. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that…
-
Reading SURMOUNT-1 without the press release Replied, post #70 · Compounds › Tirzepatide · 18 Nov 2025 · 21 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Oral semaglutide bioavailability and its variability between people Replied, post #15 · Compounds › Oral incretins · 15 Nov 2025 · 21 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
-
Thyroid function tests during substantial weight change Replied, post #133 · Clinical › Bloodwork · 13 Nov 2025 · 0 likes Picking up post #130: that is the part I would want checked first. TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #41 · Compounds › Semaglutide · 6 Nov 2025 · 1 like On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile… Replied, post #7 · Compounds › Semaglutide · 2 Nov 2025 · 12 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #8 · Start Here › Welcome · 12 Oct 2025 · 3 likes post #7 answers the question as asked. The question underneath it is different. Introducing yourself is fine and requires no question. Post in this subcategory,…
-
Thyroid function tests during substantial weight change Replied, post #89 · Clinical › Bloodwork · 9 Oct 2025 · 26 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
Follow-up: Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #9 · Practice › Dosing & titration · 7 Oct 2025 · 13 likes This follows post #6 rather than contradicting it. How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #85 · Devices › Cold chain · 4 Oct 2025 · 12 likes Freeze-thaw: some peptides tolerate freezing; others do not. Check your compound's labelling. Generally, repeated freeze-thaw is worse than single freeze-thaw.
-
Payment method and the leverage it gives you, ranked Replied, post #41 · Sourcing › Payments · 20 Sep 2025 · 0 likes post #40 is right about the mechanism and I think understates the practical bit. Payment mechanics: most suppliers accept bank transfer, crypto, and some accept credit…
-
Which panel is worth repeating and which is worth ignoring Replied, post #114 · Clinical › Bloodwork · 18 Sep 2025 · 19 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
-
What a purity-only report leaves out Replied, post #16 · Sourcing › Independent verification · 16 Sep 2025 · 0 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Second pass at: Programming during a large energy deficit Replied, post #7 · Nutrition & Training › Resistance training · 13 Sep 2025 · 4 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #84 · Data & Tools › Datasets · 9 Sep 2025 · 7 likes Bias toward positive outcomes: datasets collected by members are biased toward people who found the compounds useful. People who did not respond do not return. People…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #61 · Data & Tools › Datasets · 8 Sep 2025 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #65 · Evidence › Journal club · 1 Sep 2025 · 21 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #9 · Compounds › Tirzepatide · 30 Aug 2025 · 0 likes This follows post #6 rather than contradicting it. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #29 · Compounds › Other compounds · 27 Aug 2025 · 31 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #13 · Compounds › Tirzepatide · 25 Aug 2025 · 15 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Are there stupid questions here? A staff answer, at length Replied, post #109 · Start Here › Welcome · 24 Aug 2025 · 4 likes post #108 is right about the mechanism and I think understates the practical bit. Off-topic posts that do not belong here belong in the Lounge instead. You are not in…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #111 · Compounds › Tirzepatide · 23 Aug 2025 · 15 likes Worth separating two things that post #107 runs together. Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #38 · Evidence › Journal club · 15 Aug 2025 · 18 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #73 · Sourcing › Regulatory · 8 Aug 2025 · 4 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
When a preprint is the best available evidence and we say so Replied, post #24 · Evidence › Preprints · 4 Aug 2025 · 2 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #14 · Analytics › COA interpretation · 1 Aug 2025 · 0 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
A ten-fold dose error caught before injection — one year on Replied, post #7 · Devices › Syringes & needles · 31 Jul 2025 · 26 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #33 · Practice › Reconstitution · 29 Jul 2025 · 8 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Cagrilintide molecular characteristics and analytical considerations Replied, post #5 · Compounds › Cagrilintide & amylin analogues · 24 Jul 2025 · 31 likes The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The pharmacokinetics are the reason the dosing schedule makes sense.
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #26 · Compounds › Cagrilintide & amylin analogues · 21 Jul 2025 · 1 like Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
-
An emergency department visit, described afterwards Replied, post #44 · Safety › Adverse events · 20 Jul 2025 · 17 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #73 · Compounds › Repair & healing peptides · 18 Jul 2025 · 19 likes post #72 is right about the mechanism and I think understates the practical bit. Stability of BPC-157 in solution: what has been measured in published work covers…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #39 · Analytics › Home & field testing · 17 Jul 2025 · 2 likes On post #35 — agreed on the reasoning, with one qualification. Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids.…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #53 · Compounds › Cagrilintide & amylin analogues · 11 Jul 2025 · 9 likes On post #49 — agreed on the reasoning, with one qualification. Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #40 · Data & Tools › Calculators · 2 Jul 2025 · 21 likes On post #36 — agreed on the reasoning, with one qualification. Mass error checking: enter your observed mass and theoretical mass and check whether the difference in…
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #35 · Compounds › Cagrilintide & amylin analogues · 1 Jul 2025 · 1 like post #34 is right about the mechanism and I think understates the practical bit. For anyone arriving from searches on "amylin agonist": this subcategory discusses…
-
Repeatability versus intermediate precision Replied, post #103 · Analytics › Method validation · 30 Jun 2025 · 13 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #35 · Evidence › Journal club · 11 Jun 2025 · 3 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #62 · Access › Insurance & coverage · 11 Jun 2025 · 0 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
-
Pre-registering a personal experiment, seriously Replied, post #89 · Research Methods › N-of-1 designs · 2 Jun 2025 · 7 likes Worth separating two things that post #85 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Pregnancy as an absolute contraindication Replied, post #47 · Safety › Contraindications · 18 May 2025 · 7 likes Coming back to post #45, because the follow-up matters more than the original answer. Concurrent insulin or sulfonylureas: not an absolute contraindication but requires…
-
Ipamorelin selectivity claims and where they came from Replied, post #38 · Compounds › Secretagogues & GH axis · 16 May 2025 · 24 likes Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for what they claim: less effect on cortisol and prolactin…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #2 · Documentation › Doc review · 13 May 2025 · 24 likes I read the opening post twice before replying, because I had assumed the opposite. Citation checking: if a maintained page cites a paper, the citation should match what…
-
A supplier that answers analytical questions with restated claims Replied, post #75 · Sourcing › Red flags · 12 May 2025 · 24 likes Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and…
-
Dizziness on standing: the ordinary explanation first Replied, post #12 · Nutrition & Training › Hydration & electrolytes · 25 Apr 2025 · 0 likes Exercise and electrolyte losses: sweating during exercise increases sodium and potassium losses. Electrolyte replacement during or after intense exercise helps maintain…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #3 · Sourcing › Independent verification · 21 Apr 2025 · 4 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #84 · Evidence › Journal club · 21 Apr 2025 · 19 likes On post #80 — agreed on the reasoning, with one qualification. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence…
-
Follow-up: What other technical communities get right that we do not Replied, post #72 · Lounge › Off topic · 19 Apr 2025 · 26 likes Coming back to post #70, because the follow-up matters more than the original answer. Science communication: if you come across an interesting science paper or article…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #21 · Data & Tools › Calculators · 17 Apr 2025 · 24 likes Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors that come from forgetting units. Always verify units in and out.
-
Antibiotics and a course of something with delayed emptying Replied, post #22 · Practice › Interactions · 17 Apr 2025 · 1 like Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Requesting a page: what makes a good request Replied, post #44 · Documentation › Wiki requests · 3 Apr 2025 · 22 likes Flag a page that has drifted: if you notice a maintained page has information that is outdated (dates that have passed, regulatory changes, new evidence) post a flag so…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #66 · Compounds › Cagrilintide & amylin analogues · 30 Mar 2025 · 0 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
Checking someone else's arithmetic: a worked example thread Replied, post #33 · Practice › Reconstitution · 27 Mar 2025 · 30 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Pregnancy as an absolute contraindication — the long version Replied, post #2 · Safety › Contraindications · 24 Mar 2025 · 18 likes Coming back to the opening post, because the follow-up matters more than the original answer. Concurrent insulin or sulfonylureas: not an absolute contraindication but…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #111 · Access › International · 20 Mar 2025 · 21 likes Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #55 · Practice › Reconstitution · 16 Mar 2025 · 3 likes On post #51 — agreed on the reasoning, with one qualification. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial"…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #34 · Sourcing › Vendor reports · 16 Mar 2025 · 2 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Maintainer handover: how it works Replied, post #27 · Meta › Wiki maintenance · 14 Mar 2025 · 0 likes Outdated external links: if a maintained page links to external sources and those links are broken or pages have moved, reporting that helps keep the page current.
-
Talking to a therapist about this specifically — does this still hold? Replied, post #29 · Wellbeing › Mental health · 13 Mar 2025 · 33 likes Social and relationship impacts: weight change affects how others perceive and interact with a person. Those impacts are real and can be psychologically significant.
-
Reading an MS report that only gives you a single number Replied, post #22 · Analytics › Mass spectrometry · 5 Mar 2025 · 21 likes Worth separating two things that post #18 runs together. Purity and identity are different questions: LC-MS establishes that the species at a retention time has the…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #106 · Sourcing › Regulatory · 4 Mar 2025 · 13 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
Validating a method you did not develop — does this still hold? Replied, post #52 · Analytics › Method validation · 27 Feb 2025 · 24 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
Follow-up: What other technical communities get right that we do not Replied, post #25 · Lounge › Off topic · 25 Feb 2025 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #98 · Data & Tools › Calculators · 20 Feb 2025 · 0 likes Worth separating two things that post #94 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
When to suspect the method rather than the sample Replied, post #80 · Analytics › Method validation · 11 Feb 2025 · 2 likes post #79 is right about the mechanism and I think understates the practical bit. Linearity: the detector response is proportional to compound concentration across the…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #109 · Compounds › Tirzepatide · 19 Jan 2025 · 29 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Recovery when intake is low: what to cut first Replied, post #14 · Nutrition & Training › Resistance training · 10 Jan 2025 · 0 likes I read post #12 twice before replying, because I had assumed the opposite. Programming while losing weight quickly: realistic expectations are crucial. Strength often…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #46 · Compounds › Cagrilintide & amylin analogues · 6 Jan 2025 · 6 likes post #45 is right about the mechanism and I think understates the practical bit. The CagriSema phase 2 paper: a fixed combination of the two components in one weekly…
-
Identical chromatograms across two different lots Replied, post #67 · Sourcing › Red flags · 25 Dec 2024 · 3 likes Coming back to post #65, because the follow-up matters more than the original answer. Pricing patterns: unusually low prices for what are otherwise consistent with…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #161 · Analytics › COA interpretation · 22 Dec 2024 · 0 likes Picking up post #158: that is the part I would want checked first. When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #2 · Pharmacology › Receptor biology · 8 Dec 2024 · 0 likes Picking up the opening post: that is the part I would want checked first. GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is…
-
Washout with a one-week half-life: the arithmetic Replied, post #87 · Research Methods › N-of-1 designs · 8 Dec 2024 · 11 likes Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what…
-
Gallbladder disease risk with rapid weight loss Replied, post #25 · Clinical › Comorbidities · 30 Oct 2024 · 11 likes This follows post #22 rather than contradicting it. Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and…
-
When "no data" is the complete and final answer Replied, post #8 · Compounds › Other compounds · 23 Oct 2024 · 0 likes Worth separating two things that post #4 runs together. Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry…
-
Follow-up: Trifluoroacetate content and its consequences Replied, post #14 · Analytics › Impurities & related substances · 19 Oct 2024 · 0 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
-
Identical chromatograms across two different lots Replied, post #38 · Sourcing › Red flags · 18 Oct 2024 · 22 likes Worth separating two things that post #34 runs together. Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's…
-
Irish differences from the UK position Replied, post #20 · Regional › UK & Ireland · 3 Oct 2024 · 0 likes Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #43 · Evidence › Preprints · 29 Sep 2024 · 1 like Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
-
Blind submission and why it changes minds Replied, post #71 · Sourcing › Independent verification · 26 Sep 2024 · 13 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #30 · Analytics › COA interpretation · 17 Aug 2024 · 33 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
Blind submission and why it changes minds Replied, post #35 · Sourcing › Independent verification · 13 Aug 2024 · 18 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
Guidelines revision: what changed and why Replied, post #96 · Meta › Announcements · 28 Jul 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
The mass-error checker and its intended scope Replied, post #69 · Data & Tools › Calculators · 23 Jun 2024 · 0 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…